Showing results (11-20 of 164) with videos related to
Sort By:
Pageof 17
Hematology. American Society of Hematology. Education Program|December 9, 2023
Current use of CAR T cells to treat multiple myelomaRoss S Firestone, Sham MailankodySeminars in Oncology|May 15, 2016
ASCO Plenary Sessions: impact, legacy, futureAndrae Vandross, Vinay Prasad, Sham MailankodyJAMA Otolaryngology-- Head & Neck Surgery|July 29, 2014
Unintended consequences of expensive cancer therapeutics—the pursuit of marginal indications and a me-too mentality that stifles innovation and creativity: the John Conley LectureTito Fojo, Sham Mailankody, Andrew LoNature Reviews. Clinical Oncology|November 14, 2018
Addendum: Low-value approvals and high prices might incentivize ineffective drug developmentVinay Prasad, Christopher McCabe, Sham MailankodySeminars in Hematology|October 6, 2024
Accelerating accessibility of CAR-T/NK therapies - Are AlloCARs and rapid manufacturing platforms the road ahead in improving access in multiple myeloma?Sridevi Rajeeve, Abhinav Hoskote, Sham MailankodyClinical Lymphoma, Myeloma & Leukemia|December 10, 2014
The road to treating smoldering multiple myelomaNeha Korde, Sham Mailankody, Ola LandgrenAmerican Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 18, 2019
Many Shades of Disparities in Myeloma CareSiddhartha Ganguly, Sham Mailankody, Sikander AilawadhiHematology. American Society of Hematology. Education Program|December 9, 2022
Selecting initial therapy in CLLInhye E Ahn, Jennifer R BrownSeminars in Hematology|March 27, 2024
Therapeutic targeting of apoptosis in chronic lymphocytic leukemiaInhye E Ahn, Matthew S DavidsHematology. American Society of Hematology. Education Program|December 10, 2017
Safety profiles of novel agent therapies in CLLInhye E Ahn, Matthew S DavidsPageof 17